CKO mice display decreased skin barrier function and perturbed homeostasis. by Kevin J. Mills (9270966)

Subjects:

Data Sheet 1_Emotional prompting amplifies disinformation generation in AI large language models.docx by Rasita Vinay (21006911)

“…Introduction<p>The emergence of artificial intelligence (AI) large language models (LLMs), which can produce text that closely resembles human-written content, presents both opportunities and risks. …”

Localization and conditional deletion of C/EBP in SKH1 mouse epidermis. by Kevin J. Mills (9270966)

Subjects:

Feasibility of AI-powered assessment scoring: Can large language models replace human raters? by Michael Jaworski III (22156096)

Distribution of SNPs and their frequencies based on mutation classes. by Sadia Afrin Runa (22504971)

Conditional deletion of C/EBP in epidermis results in downregulation of transcripts and pathways associated with lipid biosynthesis in epidermis. by Kevin J. Mills (9270966)

Subjects:

Percentage of positive responses to overall satisfaction 2011/12 by A) Age and sex B) SIMD decile C) Number of Health Issues and D) Urban/Rural Class. by David Henderson (4612354)

Percentage of positive responses to access question 2011/12 by A) Age and sex B) SIMD decile C) Number of Health Issues and D) Urban/Rural Class. by David Henderson (4612354)

Correlation between protein abundances and R_5-20 z-score among cases at baseline. Protein abundances, normalized to mean 0 and variance 1, are displayed on the y-axis. (... by Spela Kokelj (8356644)

Table of Bliss synergy scores in KRAS G12C–mutant cell lines treated with AMG 510 and pemigatinib (FGFR inhibitor). by Angela Abdollahi (15166230)

Subjects:

Raw GraphPad Prism graphs with underlying values used for plotted data and measures reported. by Angela Abdollahi (15166230)

Subjects:

Distributions of singscore-based EMT scores for TCGA samples across 32 tumor types using signature genes described in Mak MP, et al. (Clin Cancer Res. 2016;22: 609–620). by Angela Abdollahi (15166230)

Subjects:

<i>FGFR1</i> siRNA knockdown synergizes with KRAS G12C inhibitors in LU99 cells. by Angela Abdollahi (15166230)

Subjects:

Table of MIA PaCa-2–resistant clones and Bliss synergy scores from the combination of AMG 510 and pemigatinib or AMG 510 and an FGFR2/3i. by Angela Abdollahi (15166230)

Subjects:

FGFR1 expression and combination effect with AMG 510 and pemigatinib in MIA PaCa-2–resistant cells. by Angela Abdollahi (15166230)

Subjects:

Tumors from vehicle-treated mice were collected at the end of study, homogenized, and assessed for expression of FGFR1, vimentin, and β-actin. by Angela Abdollahi (15166230)

Subjects:

Cell line characterization and combination effect of KRAS G12C inhibitors and pemigatinib. by Angela Abdollahi (15166230)

Subjects:

In vivo activity of KRAS G12C inhibitors and pemigatinib in the LU99 xenograft model. by Angela Abdollahi (15166230)

Subjects:

Z-score–transformed gene expression data for EMT signature genes (Mak MP, et al. Clin Cancer Res. 2016;22: 609–620). by Angela Abdollahi (15166230)

Subjects:

Table of Bliss synergy scores in KRAS G12C–mutant cells with an epithelial or mesenchymal phenotype treated with the combination of AMG 510 and pemigatinib. by Angela Abdollahi (15166230)

Subjects: